Novartis to spin off Sandoz, list it in Zurich

Completion was expected in the second half of next year, the Swiss pharma group said.

Arndt Wiegmann | Reuters

Novartis said on Thursday it would spin off Sandoz and list it on the Swiss stock exchange to create the No.1 European generics company.

“For both the innovative medicines and Sandoz businesses, the spin-off would enable enhanced focus and the ability to pursue independent growth strategies,” the Swiss pharma group said in a statement.

Completion was expected in the second half of next year, he added.

.

Completion was expected in the second half of next year, the Swiss pharma group said. Arndt Wiegmann | Reuters Novartis said on Thursday it would spin off Sandoz and list it on the Swiss stock exchange to create the No.1 European generics company. “For both the innovative medicines and Sandoz businesses, the spin-off would enable…

Leave a Reply

Your email address will not be published. Required fields are marked *